|
In some instances, the disease can cause fulminant weakness in the first few days of life. ... Distal spinal muscular atrophy (spinal CMT or HMN type II): This may clinically mimic Charcot-Marie-Tooth (CMT) disease, otherwise known as hereditary motor and sensory neuropathy (HMSN) types 1 and 2: CMT is characterized by...
|
emedicine.medscape.com/article/1181436-overview
|
|
|
|
Since January of 2003, deCODE has been working on behalf of FSMA to create a new drug for treating SMA from hits discovered in our drug screens at Aurora / Vertex. ... In October of 2009, Families of SMA licensed this series of compounds to Repligen Corporation for development as a treatment for Spinal Muscular Atrophy.
|
www.fsma.org/Research/DrugDiscovery/QuinazolineProgram/
www.fsma.org/Research/DrugDiscovery/QuinazolineProgram/
|
|
|
Paratek Pharmaceuticals Inc. and Families of Spinal Muscular Atrophy Announce a Multi-Million Dollar Award. ... First publication from the drug discovery collaboration at Paratek Pharmaceuticals that has been funded by Families of SMA.
|
A new study details the first research focused on human muscle tissue atrophied due to a genetic condition, ... Target That Could Ease Spinal Muscular Atrophy Symptoms Discovered (Jan. 12, 2009) — There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the...
|
www.sciencedaily.com/releases/2009/04/090406192233.htm
|
|
Target That Could Ease Spinal Muscular Atrophy Symptoms Discovered (Jan. 12, 2009) — There is no cure for ... Toward An Effective Treatment For Spinal Muscular Atrophy (Oct. 14, 2008) — Scientists are reporting a key advance toward developing the first effective drug treatment for spinal muscular atrophy (SMA),
|
www.sciencedaily.com/releases/2007/02/070222181101.htm
|
|
Enrollment Complete in the VALIANT Clinical Trial of Type III Spinal Muscular Atrophy Patients Funded by Families of SMA. ... First publication from the drug discovery collaboration at Paratek Pharmaceuticals that has been funded by Families of SMA.
|
The National Institute of Neurological Disorders and Stroke (NINDS) has established a model translational research program to accelerate the process of developing a safe and effective treatment for SMA -- an inherited motor neuron disease that leads to muscle ... SMA left sidebar graphic of blue fade with spinal column...
|
Families of SMA was founded in 1984 for the purpose of raising funds to promote research to find a cure for Spinal Muscular Atrophy, and to support families affected by SMA. FSMA is the largest private...
|
www.firstgiving.com/nelsonboys
www.firstgiving.com/nelsonboys
|
|
Families of SMA was founded in 1984 for the purpose of raising funds to promote research to find a cure for Spinal Muscular Atrophy, and to support families affected by SMA. FSMA is the largest private... ... Eric and I first met Jack - and hence met SMA - in 1996. The Freedman's joined the Westtown community when Al took...
|
www.firstgiving.com/deannamayer
www.firstgiving.com/deannamayer
|
|
